Tag: PrEP | Page 3 | CATIE Blog

Trois points à retenir de la Conférence AFRAVIH 2016

May 3, 2016 • By Gabriel Girard

L’AFRAVIH est une conférence scientifique, organisée tous les deux ans par l’Alliance francophone des acteurs de santé contre le VIH. Elle avait lieu cette année du 20 au 23 avril à Bruxelles, rassemblant plus d’un millier de participants, venus d’Europe, d’Afrique, d’Asie ou d’Amérique du Nord. L’AFRAVIH ouvre un espace de débat francophone unique pour les acteurs de la lutte contre le VIH et les hépatites virales. La conférence est l’occasion de discuter avec des intervenants très divers, issus du milieu communautaire, de la recherche ou de la santé publique. Difficile de faire le tri dans un programme aussi riche… Mais voici trois points à retenir de la conférence!

5 ways that PrEP highlights gender inequities in HIV

March 8, 2016 • By San Patten

One of the most memorable moments in my 20 years working in the HIV field happened in a standing-room-only meeting hall in Vienna at the International AIDS Conference in 2010. This was the moment that the clinical trial CAPRISA 004 announced proof-of-concept for prevention of HIV among women using a vaginal microbicide (1% tenofivir gel). The entire room broke out in a standing ovation and tears of joy. Finally! A prevention tool that could allow a woman to protect herself in sexual encounters, regardless of the desires and wishes of her sexual partner.

IAS 2015: A watershed moment in the HIV response

August 6, 2015 • By Tim Rogers and Sean Hosein

Vancouver is in the limelight again. This year’s International AIDS Society (IAS) Conference may have marked a watershed moment in our HIV response, with some similarity to the 1996 Vancouver AIDS conference when highly active antiretroviral therapy (HAART) hit the world stage.

“Unprotected” or “condomless”: Upgrading our HIV terminology

June 16, 2015 • By James Wilton

What do you call sex without a condom? Unprotected? Only a few years ago, you might have been correct. But a growing consensus of HIV prevention experts is shifting away from this terminology to something more accurate and more simple: sex without a condom, or condomless sex. Why? Our understanding of HIV transmission and prevention has changed dramatically in the past decade, and with it have come new words and terms. Post- and pre-exposure prophylaxis (PEP and PrEP). Undetectable viral load. Treatment as prevention.

There is a drug to prevent HIV. Why isn’t it approved in Canada?

March 30, 2015 • By Bob Leahy

Recent developments in prevention are pointing to worrying gaps in the community-based approach to HIV prevention in Canada. Perhaps we have been used to having only a single prevention technology on our books for so long – think condoms – that our ducks are not always in a row when new ones like PrEP come along. Thus potholes in our response become apparent – and none leap in to fix them. After a series of somewhat inconclusive PrEP trials, whose results were marred by adherence issues, the results of more stringent trials like the PROUD and IPERGAY studies are in,...